New York Life Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Buy |
10,623
+966
| +10% | +$16.5K | ﹤0.01% | 797 |
|
|
2025
Q1 | $616K | Buy |
9,657
+125
| +1% | +$7.98K | 0.01% | 747 |
|
|
2024
Q4 | $1.16M | Sell |
9,532
-574
| -6% | -$69.8K | 0.01% | 633 |
|
|
2024
Q3 | $1.26M | Sell |
10,106
-579
| -5% | -$72.3K | 0.01% | 655 |
|
|
2024
Q2 | $1.69M | Buy |
10,685
+971
| +10% | +$153K | 0.02% | 592 |
|
|
2024
Q1 | $1.26M | Sell |
9,714
-228
| -2% | -$29.5K | 0.01% | 631 |
|
|
2023
Q4 | $959K | Buy |
9,942
+166
| +2% | +$16K | 0.01% | 667 |
|
|
2023
Q3 | $1.19M | Buy |
9,776
+5,210
| +114% | +$632K | 0.01% | 597 |
|
|
2023
Q2 | $523K | Buy |
+4,566
| New | +$523K | 0.01% | 692 |
|